NIDA Funding Opportunities

RFA-DA-24-036: The Rural Community-Centered Drug Misuse Prevention and Harm Reduction Research: Addressing Implementation, Dissemination, and Equity Challenges across the Continuum of Care (R61/R33 Clinical Trial Only)

This notice of funding opportunity (NOFO) will support research projects that develop and test drug misuse prevention and/or harm reduction strategies, extending the continuum of care within U.S. rural communities impacted by the opioid/stimulant epidemic. The overall goal is to reduce drug use and associated risks and harms for individuals with unmet prevention and/or harm reduction needs. Research activities will be conducted in two phases (i.e., developmental R61 phase and implementation and effectiveness trial R33 phase). Each phase of the project must involve community partners and potential end users of the research findings. These projects should yield effective community-level strategies to meet prevention and/or harm-reduction needs in diverse rural communities in the U.S. Applications are due January 26, 2024.

PAR-23-270: Screening, Brief Intervention and Referral to Treatment or Prevention for Alcohol, Tobacco, and Other Drugs Use and Misuse in Adult Populations that Experience Health Disparities

Help enhance Screening, Brief Intervention and Referral to Treatment (SBIRT) with referral to preventive intervention approaches for populations that experience health disparities! The National Institutes of Health (NIH) Office of Disease Prevention (ODP) and participating Institutes, Centers, and Offices are inviting applications for research projects that test innovative approaches to implementing Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities.

This R01 funding opportunity will support clinical trial research that develops and prospectively tests implementation strategies that overcome barriers to SBIRT/P in diverse settings. Projects are strongly encouraged to include robust engagement with relevant health care and community partners and examine organizational and system contexts. First receipt date is February 5, 2024.

AND HOT OFF THE PRESS:

The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required) NOFO has now been published! Check it out here: RFA-DA-25-027: The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required) (nih.gov)

Posted 11/10/2023, updated 11/15/2023